Regenxbio (RGNX) Cash from Operations Growth (5y) (2019 - 2025)
Regenxbio (RGNX) Cash from Operations Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - |
| 2 | Nanobiotix | 1,912.31 Bn | 1,912.25 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.15 Bn | 462.36 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.00 Bn | 115.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.22 Bn | 61.47 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - |
| 8 | Argenx Se | 55.76 Bn | 50.57 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.70 Bn | 34.69 Bn | 959.66 Mn |
| 10 | Regenxbio | 506.45 Mn | 276.38 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27.16% |
| Sep 30, 2025 | -8.95% |
| Jun 30, 2025 | -18.08% |
| Mar 31, 2025 | 24.12% |
| Dec 31, 2024 | -4.39% |
| Sep 30, 2024 | -6.82% |
| Jun 30, 2024 | -13.89% |
| Mar 31, 2024 | -13.61% |
| Dec 31, 2023 | -58.00% |
| Sep 30, 2023 | -20.36% |
| Jun 30, 2023 | -21.74% |
| Mar 31, 2023 | -27.67% |
| Dec 31, 2022 | -23.28% |
| Sep 30, 2022 | -24.11% |
| Jun 30, 2022 | -45.26% |
| Mar 31, 2022 | -26.18% |
| Dec 31, 2021 | 79.67% |
| Sep 30, 2021 | -29.17% |
| Jun 30, 2021 | -33.74% |
| Mar 31, 2021 | -41.06% |